reportlinker.com/p0191852/Pharmaceuticals-Global-Industry-Guide.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pharmaceutical
Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes a five-year forecast of the industry
Americas accounts for 42.2% of the global pharmaceuticals market value.
Pfizer is the leading player in the global pharmaceuticals market, generating a 8.7% share of the market’s value.
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Table 1: Global pharmaceuticals market value: $ billion, 2007-11 21
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2011 22
Table 3: Global pharmaceuticals market share: % share, by value, 2011 23
Table 4: Global pharmaceuticals market value forecast: $ billion, 2011-16 24
Table 6: Asia-Pacific pharmaceuticals market geography segmentation: $ billion, 2011 35
Table 123: Pfizer Inc.: key facts 224
Table 124: Pfizer Inc.: key financials ($) 225
Table 125: Pfizer Inc.: key financial ratios 225
Table 126: GlaxoSmithKline Plc: key facts 227
Table 127: GlaxoSmithKline Plc: key financials ($) 228
Table 128: GlaxoSmithKline Plc: key financials () 229
Table 129: GlaxoSmithKline Plc: key financial ratios 229
Table 130: AstraZeneca PLC: key facts 231
Table 131: AstraZeneca PLC: key financials ($) 232
Table 132: AstraZeneca PLC: key financial ratios 233
Table 133: Merck & Co., Inc.: key facts 235
Table 134: Merck & Co., Inc.: key financials ($) 236
Table 135: Merck & Co., Inc.: key financial ratios 236
Table 136: Daiichi Sankyo Co., Ltd.: key facts 238
Table 137: Daiichi Sankyo Co., Ltd.: key financials ($) 239
Table 138: Daiichi Sankyo Co., Ltd.: key financials () 239
Table 139: Daiichi Sankyo Co., Ltd.: key financial ratios 239
Table 140: Astellas Pharma Inc.: key facts 241
Table 141: Astellas Pharma Inc.: key financials ($) 242
Table 142: Astellas Pharma Inc.: key financials () 242
Table 143: Astellas Pharma Inc.: key financial ratios 242
Table 144: Novartis AG: key facts 244
Table 145: Novartis AG: key financials ($) 245
Table 146: Novartis AG: key financial ratios 245
Table 147: Chiesi Farmaceutici S.P.A.: key facts 247
Table 148: Menarini Group, The: key facts 249
Table 149: Takeda Pharmaceutical Company Limited: key facts 250
Table 150: Takeda Pharmaceutical Company Limited: key financials ($) 251
Table 151: Takeda Pharmaceutical Company Limited: key financials () 251
Table 152: Takeda Pharmaceutical Company Limited: key financial ratios 251
Table 153: Mitsubishi Tanabe Pharma Corporation: key facts 253
Table 154: Mitsubishi Tanabe Pharma Corporation: key financials ($) 254
Table 155: Mitsubishi Tanabe Pharma Corporation: key financials () 254
Table 156: Mitsubishi Tanabe Pharma Corporation: key financial ratios 254
Table 157: Johnson & Johnson: key facts 256
Table 158: Johnson & Johnson: key financials ($) 257
Table 159: Johnson & Johnson: key financial ratios 257
Table 160: Jiangsu Yangtze River Pharmaceutical Group Company Ltd.: key facts 259
Table 161: Almirall S.A.: key facts 260
Table 162: Almirall S.A.: key financials ($) 260
Table 163: Almirall S.A.: key financials (€) 261
Table 164: Almirall S.A.: key financial ratios 261
Table 165: Sanofi: key facts 263
Table 166: Sanofi: key financials ($) 264
Table 167: Sanofi: key financials (€) 264
Table 168: Sanofi: key financial ratios 265
SOURCE Reportlinker